FDA Approves New Drug for Schizophrenia.

FDA Approves New Drug for Schizophrenia, Bipolar Disorder: – FRIDAY, Sept. 18, 2015 – – A fresh antipsychotic drug to treat schizophrenia and bipolar disorder in adults provides been authorized by the U.S click here . Food and Drug Administration. The drug, Vraylar , is a capsule taken once a day. Schizophrenia and bipolar disorder can be disabling and can greatly interfere with day-to-day activities, Dr. Mitchell Mathis, director of the division of psychiatry products in the FDA’s Middle for Drug Evaluation and Analysis, said within an agency news release.

18, 2015 – – Smokers have a very much higher risk for type 2 diabetes than those that never smoked, and the same holds true for those routinely exposed to secondhand smoke, a fresh study suggests. But the Harvard researchers said this increased risk drops as time passes once smokers break the addiction gradually. Cigarette smoking is highly recommended as a key modifiable risk aspect for diabetes, study co-author Frank Hu, a professor of epidemiology and diet at the Harvard T.H. Chan School of Open public Health in Boston, said in a university news discharge. Public health attempts to reduce smoking will have a considerable impact on the global burden of type 2 diabetes, Hu added. Countless studies have linked smoking to serious medical issues, including cancer, lung disease and cardiovascular disease.